Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 90. Prion Diseases
Topics: Introduction | Creutzfeldt-Jakob Disease | Fatal Familial Insomnia | Gerstmann-Sträussler-Scheinker Disease | Kuru
 
green line

Fatal Familial Insomnia

Fatal familial insomnia is a prion disease that interferes with sleep, leading to deterioration of mental function.

Fatal familial insomnia is a genetic disease, due to a specific mutation in the PrPc gene. However, the disease can occur spontaneously, without a mutation. This form is called sporadic fatal insomnia. Fatal familial insomnia and sporadic fatal insomnia differ from other prion diseases because they affect predominantly one area of the brain, the thalamus, which influences sleep.

The disease usually begins between the ages of 40 and 60 but may begin in a person's late 30s. Most often, it runs in families. At first, people may have minor difficulties falling asleep and occasional problems with muscle movements. Eventually, they lose the ability to sleep. Other changes include muscle twitching, rapid heart rate, and dementia. Death usually occurs after about 7 to 36 months of illness. No treatment is available.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.